Global Human Milk Oligosaccharides (HMO) Market Growth (Status and Outlook) 2024-2030

Global Human Milk Oligosaccharides (HMO) Market Growth (Status and Outlook) 2024-2030

The global Human Milk Oligosaccharides (HMO) market size is projected to grow from US$ 692 million in 2024 to US$ 2701 million in 2030; it is expected to grow at a CAGR of 25.5% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Human Milk Oligosaccharides (HMO) Industry Forecast” looks at past sales and reviews total world Human Milk Oligosaccharides (HMO) sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Milk Oligosaccharides (HMO) sales for 2023 through 2029. With Human Milk Oligosaccharides (HMO) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Milk Oligosaccharides (HMO) industry.

This Insight Report provides a comprehensive analysis of the global Human Milk Oligosaccharides (HMO) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Milk Oligosaccharides (HMO) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Milk Oligosaccharides (HMO) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Milk Oligosaccharides (HMO) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Milk Oligosaccharides (HMO).

The core manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, DSM (Glycom) and Chr. Hansen (Jennewein). The top three companies hold about 83% of the market. North America is the world's largest Human Milk Oligosaccharides (HMO) market with a market share of about 54%, followed by Europe and Asia Pacific with a market share of 31% and 13%, respectively. In terms of product type, 2'-FL & 3-FL is the largest segments, accounting for approximately 96% of the market share. In terms of application, Infant Formula is the largest downstream sector, accounting for about 96% of the market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Milk Oligosaccharides (HMO) market by product type, application, key players and key regions and countries.

Segmentation by Type:
2'-FL & 3-FL
LNT & LNnT, etc.

Segmentation by Application:
Infant Formula
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
2'-FL & 3-FL
LNT & LNnT, etc.

Segmentation by Application:
Infant Formula
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem

Please note: The report will take approximately 2 business days to prepare and deliver.